- Home
- BRLT vs CLNN Comparison
BRLT vs CLNN Comparison
Compare BRLT & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRLT
- CLNN
- Stock Information
- Founded
- BRLT 2005
- CLNN 2012
- Country
- BRLT United States
- CLNN United States
- Employees
- BRLT N/A
- CLNN N/A
- Industry
- BRLT Consumer Specialties
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- BRLT Consumer Discretionary
- CLNN Health Care
- Exchange
- BRLT Nasdaq
- CLNN Nasdaq
- Market Cap
- BRLT 22.4M
- CLNN 23.1M
- IPO Year
- BRLT 2021
- CLNN N/A
- Fundamental
- Price
- BRLT $1.58
- CLNN $3.65
- Analyst Decision
- BRLT Hold
- CLNN Strong Buy
- Analyst Count
- BRLT 3
- CLNN 5
- Target Price
- BRLT $1.80
- CLNN $40.00
- AVG Volume (30 Days)
- BRLT 55.4K
- CLNN 52.3K
- Earning Date
- BRLT 08-07-2025
- CLNN 08-06-2025
- Dividend Yield
- BRLT N/A
- CLNN N/A
- EPS Growth
- BRLT N/A
- CLNN N/A
- EPS
- BRLT N/A
- CLNN N/A
- Revenue
- BRLT $418,708,000.00
- CLNN $350,000.00
- Revenue This Year
- BRLT $3.79
- CLNN N/A
- Revenue Next Year
- BRLT $3.85
- CLNN $1,753.57
- P/E Ratio
- BRLT N/A
- CLNN N/A
- Revenue Growth
- BRLT N/A
- CLNN N/A
- 52 Week Low
- BRLT $1.25
- CLNN $2.28
- 52 Week High
- BRLT $2.68
- CLNN $6.96
- Technical
- Relative Strength Index (RSI)
- BRLT 60.09
- CLNN 44.42
- Support Level
- BRLT $1.35
- CLNN $3.60
- Resistance Level
- BRLT $1.80
- CLNN $3.99
- Average True Range (ATR)
- BRLT 0.11
- CLNN 0.21
- MACD
- BRLT 0.01
- CLNN -0.03
- Stochastic Oscillator
- BRLT 51.11
- CLNN 25.53
About BRLT Brilliant Earth Group Inc.
Brilliant Earth Group Inc is a digitally native omnichannel jewelry company. The company designs, procures and sells ethically-sourced diamonds, gemstones and jewelry online and through showrooms. The sales of the company consist of revenue from diamond, gemstone, and jewelry retail sales. The company sells its products in the U.S. and other international countries, of which a majority of revenue is derived from the U.S.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.